Journal of

Rheumatic Diseases and TreatmentISSN: 2469-5726

Current Issue

 Open Access DOI:10.23937/2469-5726/1510066

A Case of Hydroxychloroquine Induced Hypoglycaemia in a Non-Diabetic Patient

Richard De-Heer and Teresa Doherty

Article Type: Case Report | First Published: September 29, 2018

Hydroxychloroquine, originally used as an antimalarial agent, is now commonly prescribed for the treatment of rheumatic diseases such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE). Hydroxychloroquine associated hypoglycaemia is a rare but documented adverse effect, usually noted within the first few months of starting the medication. Here we describe the case of a patient with Rheumatoid Arthritis who developed hypoglycaemia after 7 years of treatment with a stable dose of ...

 Open Access DOI:10.23937/2469-5726/1510065

Monitoring the Time Course of Disability through a Self-Assessment Instrument "Activity Index" (IA) in RA Patients

L Ren, X Zhang, ZG Li, H Tang and R Theiler

Article Type: ORIGINAL RESEARCH | First Published: September 01, 2018

Rheumatoid arthritis (RA) is a heterogeneous autoimmune disease whose etiopathogenesis is largely unknown. Available treatments, though effective, are insufficient in so far as there is no cure for a major proportion of patients. In those patients the disease becomes chronic with progressive joint damage, disability, and limitation of participation. Current treatment approaches include pain-relieving drugs and anti-inflammatory medications that slow joint damage, combined with physical therapies...

Volume 4
Issue 3